STICH examines the role of CABG in heart failure

While the efficacy of CABG in improving both morbidity and mortality in patients with severe coronary artery disease and angina was established in the 1970’s, the majority of patients who took part in these initial ground-breaking studies had normal or near normal ventricular function.  The role of CABG in treating patients with poor systolic LV […]

Read More…

Medical therapy underused in patients undergoing PCI

Optimal medical therapy (OMT) has previously been shown to lead to similar rates of cardiovascular events as percutaneous coronary intervention (PCI) in patients with stable coronary artery disease.  Most noticeably, the COURAGE trial showed that PCI did not improve patient survival or prevent myocardial infarction.  However, it is also known that the findings of important […]

Read More…